Cargando…

Incident Diabetes Risk Is Not Increased in Transgender Individuals Using Hormone Therapy

CONTEXT: In trans women receiving hormone therapy, body fat and insulin resistance increases, with opposite effects in trans men. These metabolic alterations may affect the risk of developing type 2 diabetes in trans women and trans men. CONTEXT: We aimed to compare the incidence of type 2 diabetes...

Descripción completa

Detalles Bibliográficos
Autores principales:	van Velzen, Daan, Wiepjes, Chantal, Nota, Nienke, van Raalte, Daniel, de Mutsert, Renée, Simsek, Suat, den Heijer, Martin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2021
Materias:	Online Only Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9016430/ https://www.ncbi.nlm.nih.gov/pubmed/34971391 http://dx.doi.org/10.1210/clinem/dgab934

Ejemplares similares

Change in Visceral Fat and Total Body Fat and the Effect on Cardiometabolic Risk Factors During Transgender Hormone Therapy
por: Klaver, Maartje, et al.
Publicado: (2021)

Transgender Girls Grow Tall: Adult Height Is Unaffected by GnRH Analogue and Estradiol Treatment
por: Boogers, Lidewij Sophia, et al.
Publicado: (2022)

Prostate Cancer Incidence under Androgen Deprivation: Nationwide Cohort Study in Trans Women Receiving Hormone Treatment
por: de Nie, Iris, et al.
Publicado: (2020)

OR31-06 Gender-Affirming Hormone Therapy Affects Serum Cystatin C-based eGFR In Transgender Individuals
por: van Eeghen, Sarah A, et al.
Publicado: (2023)

SAT416 The Incidence Of Autoimmune Disease In Transgender People After Initiation Of Gender-Affirming Hormone Therapy
por: Wiepjes, Chantal, et al.
Publicado: (2023)

Response to Letter to the Editor From Laidlaw: “Erythrocytosis in a Large Cohort of Trans Men Using Testosterone: A Long-term Follow-up Study on Prevalence, Determinants, and Exposure Years”
por: Madsen, Milou C, et al.
Publicado: (2021)

Toward a Lowest Effective Dose of Cyproterone Acetate in Trans Women: Results From the ENIGI Study
por: Kuijpers, Suzanne M E, et al.
Publicado: (2021)

Breast cancer risk in transgender people receiving hormone treatment: nationwide cohort study in the Netherlands
por: de Blok, Christel J M, et al.
Publicado: (2019)

Gender-affirming Hormone Therapy and Risk of Diabetes in Transgender Persons
por: Tangpricha, Vin
Publicado: (2022)

The Role of Estrone in Feminizing Hormone Treatment
por: Tebbens, Marieke, et al.
Publicado: (2021)

Body Composition and Markers of Cardiometabolic Health in Transgender Youth Compared With Cisgender Youth
por: Nokoff, Natalie J, et al.
Publicado: (2019)

SAT411 The Influence Of Gender Affirming Hormone Therapy On Markers Of Platelet Activation In Transgender Women
por: van Zijverden, L Mees, et al.
Publicado: (2023)

Detransition Among Transgender and Gender-Diverse People—An Increasing and Increasingly Complex Phenomenon
por: Irwig, Michael S
Publicado: (2022)

The effect of transdermal gender-affirming hormone therapy on markers of inflammation and hemostasis
por: Schutte, Moya H., et al.
Publicado: (2022)

Fracture Risk in Trans Women and Trans Men Using Long‐Term Gender‐Affirming Hormonal Treatment: A Nationwide Cohort Study
por: Wiepjes, Chantal M, et al.
Publicado: (2019)

Surgery as a Viable Alternative First-Line Treatment for Prolactinoma Patients. A Systematic Review and Meta-Analysis
por: Zamanipoor Najafabadi, Amir H, et al.
Publicado: (2019)

Development of Hip Bone Geometry During Gender‐Affirming Hormone Therapy in Transgender Adolescents Resembles That of the Experienced Gender When Pubertal Suspension Is Started in Early Puberty
por: van der Loos, Maria ATC, et al.
Publicado: (2021)

SAT-LB92 Sex Hormones Therapy Differentially Modulates HDL Function in Transgender Individuals
por: Ruscica, Massimiliano, et al.
Publicado: (2020)

The Relation Between Adult Weight Gain, Adipocyte Volume, and the Metabolic Profile at Middle Age
por: Verkouter, Inge, et al.
Publicado: (2021)

Cohort Profile: Virus Watch—understanding community incidence, symptom profiles and transmission of COVID-19 in relation to population movement and behaviour
por: Byrne, Thomas, et al.
Publicado: (2023)

Clinical Factors Associated With Accurate Presumptive Treatment of Neisseria gonorrhoeae Infections in Men Who Have Sex with Men and Transgender Women
por: Anker, Bryan, et al.
Publicado: (2021)

Influence of sex hormone use on sleep architecture in a transgender cohort
por: Morssinkhof, Margot W L, et al.
Publicado: (2023)

Development of Hip Bone Geometry in Transgender Adolescents Resembles the Experienced Gender if GnRHa Treatment Is Started in Early, but Not Late, Puberty
por: van der Loos, Maria A T C, et al.
Publicado: (2021)

Trends in suicide death risk in transgender people: results from the Amsterdam Cohort of Gender Dysphoria study (1972–2017)
por: Wiepjes, C. M., et al.
Publicado: (2020)

Mapping evidence on the effects of gender-affirming hormone therapy on the hard and soft tissues of the craniofacial complex in transgender people: a protocol for a scoping review
por: Van den Bosch, M. F., et al.
Publicado: (2021)

IGSF1 Deficiency Results in Human and Murine Somatotrope Neurosecretory Hyperfunction
por: Joustra, Sjoerd D, et al.
Publicado: (2019)

Comprehensive Health Assessment 3 Months After Recovery From Acute Coronavirus Disease 2019 (COVID-19)
por: van den Borst, Bram, et al.
Publicado: (2020)

Evaluation of the 2015 ATA Guidelines in Patients With Distant Metastatic Differentiated Thyroid Cancer
por: van Velsen, Evert F S, et al.
Publicado: (2019)

Letter to the Editor from William J. Malone et al: “Proper Care of Transgender and Gender-diverse Persons in the Setting of Proposed Discrimination: A Policy Perspective”
por: Malone, William J, et al.
Publicado: (2021)

Divergent Metastatic Patterns Between Subtypes of Thyroid Carcinoma Results From the Nationwide Dutch Pathology Registry
por: Hugen, Niek, et al.
Publicado: (2019)

Interrelationships Between Pituitary Hormones as Assessed From 24-hour Serum Concentrations in Healthy Older Subjects
por: van der Spoel, Evie, et al.
Publicado: (2019)

Familial Longevity is Associated with an Attenuated Thyroidal Response to Recombinant Human Thyroid Stimulating Hormone
por: Zutinic, Ana, et al.
Publicado: (2020)

Surgical management of a perforated ‘black oesophagus’
por: Kuiper, Gino M., et al.
Publicado: (2021)

What Accounts for the Increased Incidence of Gynecomastia Diagnosis in Denmark from 1998–2017?
por: Braunstein, Glenn D
Publicado: (2020)

Growth Hormone Receptor (GHR) 6Ω Pseudoexon Activation: A Novel Cause of Severe Growth Hormone Insensitivity
por: Cottrell, Emily, et al.
Publicado: (2021)

Increasing Incidence of Primary Aldosteronism in Western Sweden During 3 Decades – Yet An Underdiagnosed Disorder
por: Gkaniatsa, Eleftheria, et al.
Publicado: (2021)

Cohort Profile: The Birhan Health and Demographic Surveillance System
por: Bekele, Delayehu, et al.
Publicado: (2021)

Changes in Serum Testosterone and Adrenal Androgen Levels in Transgender Women With and Without Gonadectomy
por: Collet, Sarah, et al.
Publicado: (2022)

Thyroid Hormone Abuse in Elite Sports: The Regulatory Challenge
por: Gild, Matti L, et al.
Publicado: (2022)

Data Resource Profile: The Integrated Primary Care Information (IPCI) database, The Netherlands
por: de Ridder, Maria A J, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_pdknr0785h9kof5a00s20h1rhq